85 related articles for article (PubMed ID: 2778677)
1. Variable effects of laurocapram (Azone) on rectal cefoxitin absorption in rats.
van Hoogdalem EJ; de Best MA; de Boer AG; Breimer DD
J Pharm Sci; 1989 Aug; 78(8):691-2. PubMed ID: 2778677
[No Abstract] [Full Text] [Related]
2. Topical effects of absorption enhancing agents on the rectal mucosa of rats in vivo.
van Hoogdalem EJ; Vermeij-Kerrs C; de Boer AG; Breimer DD
J Pharm Sci; 1990 Oct; 79(10):866-70. PubMed ID: 2280353
[TBL] [Abstract][Full Text] [Related]
3. Absorption enhancement of rectally infused cefoxitin sodium by medium-chain fatty acids in conscious rats: concentration-effect relationship.
van Hoogdalem EJ; Hardens MA; de Boer AG; Breimer DD
Pharm Res; 1988 Jul; 5(7):453-6. PubMed ID: 3247317
[TBL] [Abstract][Full Text] [Related]
4. Absorption enhancement of rectally infused cefoxitin by medium chain monoglycerides in conscious rats.
Watanabe Y; van Hoogdalem EJ; de Boer AG; Breimer DD
J Pharm Sci; 1988 Oct; 77(10):847-9. PubMed ID: 3236226
[TBL] [Abstract][Full Text] [Related]
5. 3-Amino-1-hydroxypropylidene-1,1-diphosphonate (APD): a novel enhancer of rectal cefoxitin absorption in rats.
van Hoogdalem EJ; Wackwitz AT; de Boer AG; Breimer DD
J Pharm Pharmacol; 1989 May; 41(5):339-41. PubMed ID: 2569522
[TBL] [Abstract][Full Text] [Related]
6. Rectal absorption enhancement of cefoxitin and desglycinamide arginine vasopressin by sodium tauro-24,25-dihydrofusidate in conscious rats.
van Hoogdalem EJ; Heijligers-Feijen CD; Mathôt RA; Wackwitz AT; van Bree JB; Verhoef JC; de Boer AG; Breimer DD
J Pharmacol Exp Ther; 1989 Nov; 251(2):741-4. PubMed ID: 2810123
[TBL] [Abstract][Full Text] [Related]
7. The enhancing mechanism of capric acid (C10) from a suppository on rectal drug absorption through a paracellular pathway.
Takahashi H; Shibasaki T; Takeshita K; Kaiho F; Hayashi M
Biol Pharm Bull; 1997 Apr; 20(4):446-8. PubMed ID: 9145228
[TBL] [Abstract][Full Text] [Related]
8. Effect of triglyceride on small intestinal absorption of cefoxitin in rats.
Yoshitomi H; Nishihata T; Frederick G; Dillsaver M; Higuchi T
J Pharm Pharmacol; 1987 Nov; 39(11):887-91. PubMed ID: 2892911
[TBL] [Abstract][Full Text] [Related]
9. Intestinal absorption of sodium cefoxitin in rats: effect of formulation.
Nishihata T; Yoshitomi H; Higuchi T
J Pharm Pharmacol; 1986 Jan; 38(1):69-70. PubMed ID: 2869133
[TBL] [Abstract][Full Text] [Related]
10. Effect of PEG 400, ethanol and laurocapram (Azone) on the transport of testosterone through rat skin.
Singh J; Satyanarayana S; Singh S
Pharmazie; 1992 Dec; 47(12):948-9. PubMed ID: 1293619
[No Abstract] [Full Text] [Related]
11. Enhanced bioavailability of cefoxitin using palmitoylcarnitine. II. Use of directly compressed tablet formulations in the rat and dog.
Sutton SC; LeCluyse EL; Engle K; Pipkin JD; Fix JA
Pharm Res; 1993 Oct; 10(10):1516-20. PubMed ID: 8272416
[TBL] [Abstract][Full Text] [Related]
12. Rate-controlled rectal absorption enhancement of cefoxitin by co-administration of sodium salicylate or sodium octanoate in healthy volunteers.
Van Hoogdalem EJ; Wackwitz AT; De Boer AG; Cohen AF; Breimer DD
Br J Clin Pharmacol; 1989 Jan; 27(1):75-81. PubMed ID: 2706190
[TBL] [Abstract][Full Text] [Related]
13. Influence of limonene and laurocapram on percutaneous absorption of nonsteroidal anti-inflammatory drugs.
Priborský J; Takayama K; Obata Y; Príborská Z; Nagai T
Arzneimittelforschung; 1992 Feb; 42(2):116-9. PubMed ID: 1610418
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of skin penetration-enhancing effect by laurocapram.
Sugibayashi K; Nakayama S; Seki T; Hosoya K; Morimoto Y
J Pharm Sci; 1992 Jan; 81(1):58-64. PubMed ID: 1619571
[TBL] [Abstract][Full Text] [Related]
15. Possible mechanism behind the adjuvant action of phosphate derivatives on rectal absorption of cefoxitin in rats and dogs.
Nishihata T; Lee CS; Nghiem BT; Higuchi T
J Pharm Sci; 1984 Nov; 73(11):1523-5. PubMed ID: 6520749
[TBL] [Abstract][Full Text] [Related]
16. Effect of Azone on the percutaneous absorption of 5-fluorouracil from gels in hairless rats.
Hosoya K; Shudo N; Sugibayashi K; Morimoto Y
Chem Pharm Bull (Tokyo); 1987 Feb; 35(2):726-33. PubMed ID: 3594683
[No Abstract] [Full Text] [Related]
17. Combination effect of penetration enhancers and propylene glycol on in vitro transdermal absorption of insulin.
Príborský J; Takayama K; Nagai T; Waitzová D; Elis J
Drug Des Deliv; 1987 Dec; 2(2):91-7. PubMed ID: 3334547
[TBL] [Abstract][Full Text] [Related]
18. The synergistic effects of concurrent administration to rats of EDTA and sodium salicylate on the rectal absorption of sodium cefoxitin and the effects of inhibitors.
Nishihata T; Lee CS; Rytting JH; Higuchi T
J Pharm Pharmacol; 1987 Mar; 39(3):180-4. PubMed ID: 2883281
[TBL] [Abstract][Full Text] [Related]
19. A pharmacokinetic model for the percutaneous absorption of indomethacin and the prediction of drug disposition kinetics.
Ogiso T; Ito Y; Iwaki M; Atago H
J Pharm Sci; 1989 Apr; 78(4):319-23. PubMed ID: 2724095
[TBL] [Abstract][Full Text] [Related]
20. Effect of topical laurocapram (Azone) on the in vitro percutaneous permeation of sodium lauryl sulfate using human skin.
Szolar-Platzer C; Patil S; Maibach HI
Acta Derm Venereol; 1996 May; 76(3):182-5. PubMed ID: 8800295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
